GlassScriptPhysician profile
Adheesh Agnihotri
NPI 1407873490
$25,881.63
in general payments reported to CMS, 2019-2025
25 companies · $7,178 in 2025
The $7,178 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,176 · 2021: $764 · 2022: $1,096 · 2023: $541 · 2024: $14K · 2025: $7,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $4,374 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,471.23 |
| Food and Beverage | $4,373.52 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $17,153.02 | 2021-2025 | Selectra, Solia, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $2,634.06 | 2021-2025 | Ensite, Aveir, Ensite Precision |
| Medtronic Vascular, INC. | $1,991.18 | 2019 | |
| Biosense Webster, INC. | $849.75 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $742.78 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Farapulse, Accolade Sr |
| Impulse Dynamics (USA) INC. | $540.74 | 2022-2025 | Optimizer |
| Medtronic, INC. | $366.10 | 2021-2025 | Pulseselect, Arctic Front Advance, Affera Mapping System |
| Amgen INC. | $168.64 | 2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $165.82 | 2025 | Wainua, Farxiga |
| Philips North America LLC | $165.60 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.67 | 2021-2025 | Lifevest |
| Atricure, INC. | $143.20 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Esperion Therapeutics, INC. | $142.41 | 2024-2025 | Nexletol |
| Cvrx, INC. | $142.19 | 2021-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $136.20 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.73 | 2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $74.60 | 2023 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $50.59 | 2025 | Camzyos |
| Novo Nordisk INC | $36.78 | 2024-2025 | Wegovy, Ozempic |
| Sanofi-Aventis U.S. LLC | $33.10 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.91 | 2025 | |
| Zoll Respicardia, INC. | $21.62 | 2025 | Remede System |
| Elutia, INC. | $20.48 | 2021 | |
| Lilly USA, LLC | $14.95 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $13.51 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adheesh Agnihotri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.